Friday, May 3, 2013

SAN ANTONIO, Texas — Omalizumab (Xolair, Roche, Genentech, Novartis) appears to be safe and effective in the treatment of chronic idiopathic urticaria that is refractory to antihistamines, according to new phase 3 clinical trial results.(from Medscape)


Safety Of Triclosan, Antibacterial Soap Ingredient, Being Reviewed By FDA 

It's a chemical that's been in U.S. households for more than 40 years, from the body wash in your bathroom shower to the knives on your kitchen counter to the bedding in your baby's bassinet... The agency's review comes amid growing pressure from lawmakers, consumer advocates and others who are concerned about the safety of Triclosan. Recent studies of Triclosan in animals have led scientists to worry that it could increase the risk of infertility, early puberty and other hormone-related problems in humans.   By MATTHEW PERRONE

Post a Comment